Cleveland BioLabs
CBLI
#9803
Rank
NZ$84.49 M
Marketcap
NZ$5.46
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: NZ$84.49 Million

As of December 2025 Cleveland BioLabs has a market cap of NZ$84.49 Million. This makes Cleveland BioLabs the world's 9803th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$77.28 M7.58%
2021NZ$71.83 M15.43%
2020NZ$62.23 M516.26%
2019NZ$10.09 M-40.64%
2018NZ$17.01 M-73.29%
2017NZ$63.68 M182.76%
2016NZ$22.52 M-59.8%
2015NZ$56.02 M169.45%
2014NZ$20.79 M-67.68%
2013NZ$64.32 M-11.05%
2012NZ$72.31 M-44.43%
2011NZ$0.13 B-51.98%
2010NZ$0.27 B194.35%
2009NZ$92.07 M83.16%
2008NZ$50.26 M-66.08%
2007NZ$0.14 B75.15%
2006NZ$84.6 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
NZ$35.99 M-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ$1.88 B 2,132.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$294.62 B 348,592.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$438.03 B 518,310.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
NZ$183.72 B 217,340.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$204.61 B 242,061.61%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$169.60 B 200,625.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ$28.65 M-66.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.586 T 1,877,123.72%๐Ÿ‡บ๐Ÿ‡ธ USA